What I can say is that we agree it is important to rebuild our life sciences sector. That's why my colleague Minister Champagne has been working so closely with a number of pharmaceutical companies, including Novavax and many others, to look at how we can strengthen Canada's footprint in biomanufacturing and the life sciences sector.
Of course, when we do that with the many companies that are interested, actually, in coming to Canada and being part of that sector, with a footprint here, it is an opportunity to strengthen the connection with research and science in that space as well. I'm very excited about that work, and I know that the minister would be happy to speak about the ongoing conversations with the pharmaceutical companies and their eagerness to be here in Canada.